Skip to main content
. 2013 Apr 25;8(4):e62418. doi: 10.1371/journal.pone.0062418

Figure 1. Decreased expression of NKG2D and NKp46 on NK cells from type 2 diabetes patients.

Figure 1

(A) Representative gating on CD3−/CD56+, CD56bright CD16dim/ne, CD56dim CD16bright and CD56 CD16+ cells. (B) NKG2D expression on NK cells from 25 healthy donors (HD) and 35 type 2 diabetic patients (T2D) as assessed by flow cytometry. One representative flow cytometry experiment is shown. (C) NKp46 expression quantified by FACS (n = 25); a representative analysis is shown. (**: P<0.01).